CURACYTE AG
Curacyte AG is a bio pharmaceutical company that develops therapeutics for acute and critical care.
CURACYTE AG
Social Links:
Industry:
Biotechnology
Founded:
2001-01-01
Address:
München, Bayern, Germany
Country:
Germany
Website Url:
http://www.curacyte.eu
Total Employee:
11+
Status:
Active
Contact:
+498941200681
Total Funding:
74.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Nginx DigiCert SSL CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
CeNeS Pharmaceuticals
CeNeS Pharmaceuticals is a biopharmaceutical company that develops and commercializes.
Corticrine
Corticrine operates as a pharmaceutical company that develops new therapies for Alzheimer’s dementia.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2002-06-10 | VitaResc Biotech AG | VitaResc Biotech AG acquired by Curacyte AG | N/A |
Investors List
Thuja Capital
Thuja Capital investment in Venture Round - Curacyte AG
TVM Capital
TVM Capital investment in Series C - Curacyte AG
IBG Beteiligungsgesellschaft Sachsen-Anhalt
IBG Beteiligungsgesellschaft Sachsen-Anhalt investment in Series C - Curacyte AG
Official Site Inspections
http://www.curacyte.eu
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Curacyte AG"
Curacyte AG - Crunchbase Company Profile & Funding
Curacyte AG closed its last funding round on Apr 1, 2007 from a Venture - Series Unknown round. Who are Curacyte AG 's competitors? Alternatives and …See details»
Curacyte Company Profile 2024: Valuation, Funding & Investors
Curacyte General Information Description. Developer of advanced biopharmaceutics intended to treat acute and critical diseases. The company's advanced biopharmaceutics develops new …See details»
Curacyte - Products, Competitors, Financials, Employees, …
Curacyte is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. Use the CB Insights Platform to explore Curacyte's full …See details»
Curacyte (Group) - Life-Sciences-Europe.com
Feb 1, 2001 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) EuropaBio aisbl – the European Association of Bioindustries; BioIndustry …See details»
Curacyte AG - Orphanet
EC Expert Group on Rare Diseases (EU) European Reference Networks; OJRD; Orphanet Report Series. X. Share; Share; ... Curacyte AG. Curacyte AG c/o Dornbach GmbH. Arnulfstraße 39. …See details»
Curacyte AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Curacyte AG with its drug pipeline, therapeutic area, technology platform, 1 literature, Drug:VTR-TI, VTR-4, CD-160130, Pyridoxalated haemoglobin polyoxyethylene, IBFB-120082.See details»
Curacyte - VentureRadar
Apart from hemoximer, Curacyte is also developing a first-in-class small molecule protease inhibitor for prevention of blood loss following cardiac surgery. The development candidate is …See details»
Curacyte AG - Funding, Financials, Valuation & Investors
Curacyte AG has acquired VitaResc Biotech AG on Jun 10, 2002. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 4. ... How much funding …See details»
Curacyte and IBFB Pharma annouce merger - bionity.com
Curacyte AG has announced its merger with IBFB PHARMA GmbH. Curacyte AG will remain a financial holding with three wholly owned operating subsidiaries in Leipzig, Jena (Germany) …See details»
Curacyte AG - Contacts, Employees, Board Members, Advisors
Curacyte AG is a bio pharmaceutical company that develops therapeutics for acute and critical care.See details»
Curacyte, VitaResc Merging As Part Of German Consolidation
Jun 12, 2002 Curacyte, which is based in Munich, has concentrated on discovering and developing clinical products for the fields of hematology, antithrombosis and oncology. As part …See details»
Curacyte - Overview, News & Competitors | ZoomInfo.com
Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform …See details»
Curacyte AG Sells Its Subsidiary Curacyte Discovery GmbH to
Curacyte received a payment of € 14.5 million upon signing of the agreement. In addition, Curacyte will be eligible to receive a payment of € 10.5 million when The Medicines Company …See details»
Curacyte AG Asset Profile | Preqin
Curacyte is a Germany-based biopharmaceutical company that operates as a developer of therapeutics for acute and critical care applications. ... www.curacyte.eu Total Amount Raised …See details»
Curacyte Sells Its Subsidiary Curacyte Discovery GmbH to The …
Aug 6, 2008 Curacyte received a payment of € 14.5 million upon signing of the agreement. In addition, Curacyte will be eligible to receive a payment of € 10.5 million when The Medicines …See details»
Curacyte Discovery GmbH - Crunchbase Company Profile & Funding
Organization. Curacyte Discovery GmbH . Connect to CRM . Save . Summary. People. Signals & News. ... (EU), Europe, Middle East, and Africa ... Curacyte Discovery GmbH is a …See details»
Is Curacyte AG late reporting EU clinical trials?
Related organisations. Over time organisations can merge, or split. We think Curacyte AG is now also responsible for the trials of: Apex Bioscience, Inc.See details»
EU/3/07/487 - orphan designation for treatment of chronic …
On 14 November 2007, orphan designation (EU/3/07/487) was granted by the European Commission to Curacyte Discovery GmbH, Germany, for 4-ethoxy-2-(piperazin-1-yl)-7-(pyridin …See details»
ABOUT – curate-d.eu
The Erasmus+ Project “CURATE-D:A Game-based methodology for empowering Dementia friendly communities and equal access to Culture for people with Dementia” is a project aiming …See details»
curate-d.eu
The project «A Game-based methodology for empowering Dementia friendly communities and equal access to Culture for people with Dementia» – CURATE-D aims to create a game-based …See details»